Professional Documents
Culture Documents
Guidelines Inpatient Pharmacy Practice
Guidelines Inpatient Pharmacy Practice
CEUTICAL SER
VICES DIVISION
PHARMACEUTICAL
SERVICES
MINISTR
Y OF HEAL
TH MAL
AYSIA
MINISTRY
HEALTH
MALA
GUIDELINES FOR
INPATIENT
PHARMAC Y
PRACTICE
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
PREFACE
Director
Pharmacy Practice and Development Division
Ministry Of Health Malaysia
Pharmacy Practice and Development Division has been evolving and this is evidenced
through years of excellence in performance. Primarily focussed on patient safety, we
are responsible for the optimisation of drug therapy and prevention of medication errors.
Throughout the expansion of services, Pharmacy Practice and Development
Division has introduced standardisation of procedures towards assisting proper
management of Drug Distribution and Ward Pharmacy activities. This Guidelines for
Inpatient Pharmacy Practice will serve as a tool for all to work conscientiously for the
benefit of patients.
This guideline focuses on good management of drug distribution describes work
flows of the Inpatient Pharmacy processes and explanation of the necessary
documents involved. It is hoped that the guidelines are able to steer good
management practice in conducive environments towards fulfilment of customers'
needs.
I would like to convey my gratitude to the Clinical & Technical Pharmacy Working
Committee in the success of producing this guideline. Also, a special thanks to all
parties that contributed during all stages of development and publication of this
guideline.
Thank you
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Table of Contents
Page
Preface
Table of Contents
Editorial Board
2.7
10
10
16
17
17
17
18
19
21
22
22
23
25
26
24
28
30
31
31
32
33
33
5.0 Documentations
34
6.0 Reference
40
7.0 Appendices
41
8.0 Glossary
67
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Editorial Board
Advisors
Eisah A Rahman
Senior Director of Pharmaceutical Services,
Ministry of Health Malaysia
Hasnah Ismail
Director of Pharmacy Practice and Development
Pharmaceutical Services Divison, MOH
Editors
Abida Haq Syed M. Haq
Deputy Director
Pharmaceutical Services Division, MOH
Ainul Salhani Abdul Rahman
Principal Assistant Director
Pharmaceutical Services Division, MOH
Rabi'ah Mamat
Principal Assistant Director
Pharmaceutical Services Division, MOH
Phuar Hsiao Ling
Senior Assistant Director
Pharmaceutical Services Division, MOH
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
GUIDELINES FOR
INP
ATIENT PHARMA
CY
INPA
PHARMAC
PRACTICE
PRA
CTICE
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
1.0
Pharmacy
Services
1.0
Pharmaceutical care is an area in the health care system which has yet to be fully
developed in Malaysia although it has generated tremendous impact worldwide. Since
its inception in the 1990's, Malaysian pharmacists have embarked on a bold and
dramatic leap forward to embrace its philosophy in all areas of pharmaceutical care
services. Much effort has been put into exploring ways in which to instil and initiate
pharmaceutical care activities in both the outpatient and inpatient settings.
Ward pharmacy activities encompass issues on all aspects of pharmacotherapy. During
ward rounds, input pertaining to appropriateness of therapy, counselling of patients on
medication therapy and the monitoring of unwanted side effects are the major
services provided. Often time, the input given is not documented. Thus, a mechanism
to document these activities is crucial and urgently required.
The pharmaceutical needs of a patient refer to his or her requirements for pharmaceutical
products or services. Pharmaceutical needs may be identified by any member of the
health care team or by the patient him/herself. Once a targeted patient group has been
assigned to the responsibility of a clinical pharmacist, a function of the delivery of the
service is to prioritise the individual patient in the group according to his/her potential
pharmaceutical care issues (PCI).
It is important to document the outcomes of the pharmaceutical care intervention for
the purpose of individual patient records as well as information for the management.
Information on issues such as drug availability, dosage form, procurement and
storage should be managed in liaison with colleagues in other units. Pharmacists
require both knowledge and clinical experience to be a useful member of the health
care team. Therefore the clinical pharmacist serves as a liaison person between
patients, doctors, nurses and fellow pharmacists.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Inpatient Pharmacy
Services
Inpatient
2.0
Drug
Distribution
2.0
Activities
Objectives
Drug Distribution
Activities
The pharmacy department should implement a distribution system that meets the
following objectives:
i. To dispense prescribed drugs to patients in wards in a timely and efficient
manner
ii.
2.1
All medications dispensed to patients in the wards should be kept in individually labelled
drawers or trays in the medication trolleys for patients. The amount of medication
dispensed should be according to the dosage regimen and placed in compartments
within the patient drawers. The medication trolley must be lockable and the keys kept
by a registered nurse in the specific ward and another by an authorised pharmacy
staff.
10
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Drug
2.1.1
Distribution
Activities
2.0
2. The trolley has to be collected by ward staff before the next dose
administration time at 12.00 noon.
2.1.2
Medication Order
1. The medication order for ward patients must be completed in the
self-carbonised Medication Chart and signed by the prescriber
according to the categories set by the Ministry of Health Malaysia
Drug Formulary (FUKKM).
2. Each prescription must be written with the generic name, complete
with dose in mg, ml or IU; administration route such as SC, IM, IV,
PO, LA or others; administration frequency such as DAILY, BD, TDS,
QID etc; treatment duration such as 5/7, 1/52 or 2/52; starting date;
prescriber's signature; patient name and ward/bed number.
3. All prescriptions of medications for A, A/KK or A* categories must be
stamped and countersigned by the relevant specialist. Controlled
medicines must be attached with application forms according to the
practice in individual institutions.
4. All original prescriptions (white) from the Medication Chart should
be separated from the carbonised copy (yellow) (Appendix 1). The
carbonised copy should be retained in the ward.
5. A new medication order (prescription) must be made in the following
situations:
a) Newly-admitted patients
b) Patients transferred in from other wards
c) Patients who have just undergone an operation or special
procedures
d) Expired prescriptions but treatment needs to be continued
6. For patients who have just been admitted into the ward, the
prescription has to be sent with the patient's Cumulative Medication
Record (Appendix 2).
7. For patients currently in the ward, any addition of medications must
be made through a prescription. Any changes in dose, dosage form,
frequency or treatment duration warrants a new prescription attached
with an Advice Note (Appendix 3).
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
11
Drug Distribution
Activities
2.0
Drug
Distribution
Activities
2.1.3
12
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Drug
Distribution
Activities
2.0
Date Start
PATIENT'S NAME
C16-B2 Ooi Chooi Seng
12/10/09
DRUG
Prescriber's
signature &
stamp
Dose
Route
1/1
PO
12/10/09
Amount
Date
Amount
NOTES
1 x 1
Drug Distribution
Activities
Date
MEDICATION RECORD
Frequency Duration
Daily
7/7
Filling of Prescriptions
1. All medications supplied to the ward must be in ready-to-use form in
a container meant for administration of one dose and not exceeding
the requirements for 24 hours.
2. Filling of prescription should be done by the Pharmacist/ Pharmacy
Assistant and counterchecked by another Pharmacist.
3. Filling has to be done for new prescriptions and current prescriptions
in the CMR.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
13
2.0
Drug
Distribution
Activities
Drug Distribution
Activities
DATE
12/10/09
AMOUNT DATE
AMOUNT DATE
AMOUNT NOTES
2X4
Frequency
14
Time
4 hourly
QID
TDS
8 am, 2 pm, 8 pm
BD
8 am, 8 pm
ON
10 pm
OM
8 am
Before meal
6 am
Before meal BD
prn
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Drug
Distribution
Activities
2.0
DATE
AMOUNT DATE
12/10/09 1 x 5ml
atau
1 x 30g
AMOUNT DATE
AMOUNT NOTES
...............................................................
...............................................................
DATE
AMOUNT
12/10/09
+8
13/10/09
+6
14/14/09
+2
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
15
Drug Distribution
Activities
2.0
Drug
Distribution
Activities
AMOUNT
Drug Distribution
Activities
12/10/09
1x3+3
13/10/09
1 x 3 + 0 (not added)
14/14/09
1x3+2
The staffs filling the bins have to sign the Unit Dose Dispensing
Checklist (Appendix 5).
2.1.5
2.2
16
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Drug
Distribution
Activities
2.0
The procedures for supplying Floor Stock / Emergency Trolley Medications are as
follow:
1. Receive medication order book from the ward / unit
2. Check balance of floor stock / emergency trolley medications
3. Record the quantity supplied in the order book
Drug Distribution
Activities
2.3
Drugs prescribed after normal working hours will be supplied according to the amount
requested to the pharmacy staff on-call.
2.4
Wards may only keep psychotropic medicines in the amount permitted in a medication
list. A copy of the medication list as agreed upon by the pharmacy and the ward / unit
should be kept in the ward / unit and pharmacy. Record books must be updated each
time psychotropic medications are used based on valid prescription (order form).
The procedures for supply of psychotropic medicines are as follow:
1. Receive order form and psychotropic medications record book from the ward
/ unit.
2. Check order form and record of psychotropic medication use
3. Determine that the order is consistent with use and record the balance of
psychotropic medications
4. Record supply in the psychotropic medications register book
5. Record the quantity supplied and sign the psychotropic medications record
book and order form
2.5
Supplies for discharged patients should follow the same procedures as that of
dispensing at the counter. However for medication counselling (refer Chapter 3.5) and
bedside dispensing (refer Chapter 3.6), should ideally be carried out for the following
category of patients:
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
17
2.0
Drug
Distribution
Activities
1. Patients using devices (inhalers, insulin pen); to reinstate what has been taught
during ward stay.
2. Patients with several debilitating conditions who are on many different
medications.
3. Patients newly diagnosed with chronic illnesses
Drug Distribution
Activities
2.6
The policy of Ministry of Health Malaysia stated that stable patients can be referred to
nearby health facilities (hospital or health clinic) by using referral letter, for the purpose
of continuing treatment. Proper handling of referral letter (second copy) and supply of
medications to referred patients are important since not all facilities keep certain
medicines. Pharmacy Department is responsible in ensuring that there is a policy/
procedure regarding the submission of referral letter (second copy) to Pharmacist at
the facility where the patient is referred to.
Objectives of proper handling of referral letter:
2.6.1
The first copy is for the patient to bring to the referred facility
18
If the referred facility does not keep the medicines, the referring
facility must supply enough medication until the next
appointment date at the referred facility
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Ward
Activities
3.0
3. Pharmacist at the referring facility must fax or post the second copy
of the referral letter to the Pharmacist at the referred facility, and if
necessary supply the medications to the referred facility before the
next appointment date
4. A copy of the second copy of the referral letter should be filed for
reference purposes
2.6.2
2.7
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
19
Drug Distribution
Activities
Pharmacy
2.0
Drug
Distribution
Activities
Drug Distribution
Activities
20
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Ward
3.0
Pharmacy
Activities
3.0
Ward Pharmacy activities should be in line with the concept of Pharmaceutical Care
i.e. patient-centred, outcomes-oriented pharmacy practice. It requires the pharmacist
to work in concert with other healthcare providers to promote health, to prevent
disease, and to assess, monitor, initiate and modify medication towards ensuring that
drug therapy regimens are safe and effective.
ii.
Ward Pharmacy
Activities
The goal of ward pharmacy activities is to optimise the patient's pharmacotherapy and
achieve positive clinical outcomes within realistic economic expenditures. Four types
of forms are designed to document ward pharmacy activities:i. Medication History Assessment Form (CP1)
Pharmacotherapy Review (CP2)
Case Clerking
Medication Reconciliation
Establish and maintain professional relationships with patients and other healthcare team
members.
Evaluate patient-specific medical information and develop good rapport with patients.
Ensure that the patient has all supplies, information and knowledge necessary to carry
out the drug therapy plan.
Review, monitor and modify therapeutic plan when necessary and in concert with the
patient and healthcare team.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
21
3.0
Ward
3.1
Pharmacy
Activities
Ward Pharmacy
Activities
The Medication History Assessment Form (CP1) should be used as a guide for effective
medicine history taking. The form should be kept with the patient's case notes to serve
as a reference for other healthcare providers.
Important Points for Effective Medication History Taking
List
all current medications,
including self-prescribed medication supplements and herbal
3.4
MEDICATION
REVIEWING
preparations with dosages and dates of commencement.
Record any problem related to medications (e.g.: storage, supply, containers, labelling etc).
22
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Ward
Pharmacy
Activities
3.0
Case clerking should be done for all new admissions as far as possible. The subsequent
revision of the case is known as case reviewing. Recurrent admissions should be
treated as new admissions, thus requiring new case clerking to be performed. All
findings, suggestions and interventions performed pertaining to PCIs during case
clerking / reviewing should be documented in the Pharmacotherapy Review Form (CP2)
for continuous follow-up to achieve targeted pharmaceutical outcomes.
Once the form is completed, the case should be reviewed and updated on a daily
basis until the patient is discharged. Patient's progress should be monitored by
analysing objective and subjective parameters, updating current pharmaceutical care
issues and intervening accordingly when necessary.
Able to extract relevant information from medication chart, case notes, laboratory data,
Medication History Assessment Form and relevant details from patient interview
Identify PCI
3.3
PHARMACOTHERAPY ROUNDS
Active participation in ward rounds requires good rapport with other healthcare teams,
up to date knowledge on drugs and information on drug availability and dosage forms.
The following 4P easy steps should be adapted to get started: Prepare, Participate,
Perform and Prove.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
23
Ward Pharmacy
Activities
3.0
Ward
Pharmacy
Activities
STEP 1: PREPARE
Familiarise oneself with drugs commonly used in the ward. Create your own pocket-size
drug reference
e.g.: drug list, normal dose, dosage adjustment in renal/hepatic failure
Bring along necessary forms, documents, references and other helpful tool, e.g.: calculator,
PDA, stamp
Review medication chart and patient's progress notes to identify cases that need to be
monitored
Ward Pharmacy
Activities
STEP 2: PARTICIPATE
Be discreet about what is discussed in the presence of the patient and caregivers.
STEP 3: PERFORM
STEP 4: PROVE
24
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Ward
3.4
Pharmacy
Activities
3.0
MEDICATION REVIEWING
Ensure that medication order is comprehensible and in accordance with local requirements
Ensure that any drug / food allergens are documented / displayed prominently in the
patient's case notes / records
Ensure that all ceased orders are cancelled in patient's drug profile drug order form
3.5
MEDICATION RECONCILIATION
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
25
Ward Pharmacy
Activities
3.0
Ward
ii.
Pharmacy
Activities
Ward Pharmacy
Activities
26
dosage regimen
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Ward
Pharmacy
Activities
3.0
storage conditions
Ward Pharmacy
Activities
STEP 1: PLAN
Prioritise potential patient for counselling based on:
Compliance status
Patient with special device needs
Patient dependant on caregiver.
Decide the type of counselling needed for each individual patient. For those with similar
medical problems / drug therapy, group counselling can be recommended.
STEP 2: PREPARE
Study the patient medication profile, relevant medical history, social history and other
related information prior to counselling.
Select counselling tools (eg. flip chart, pamphlet, sample device etc).
STEP 3: CONDUCT
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
27
3.0
Ward
Pharmacy
Activities
Ensuring continuity of care when patients are transferred from one hospital to another
institution requires effective cooperation between fellow pharmacists and doctors to
whom responsibilities are transferred.
The objectives of discharge planning are:
i. To reduce medication discrepancies after the patient is discharged from the
ward
ii.
3.7.1
3.7.2
28
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Ward
Pharmacy
Activities
3.0
screening and counterchecking for any errors. If any error is detected, the
inpatient / satellite pharmacist should call the ward pharmacist to do the
intervention. Discharge medication will be prepared by the inpatient / satellite
pharmacist and sent to the ward for bedside dispensing.
Use of Patient's Own Drugs for Discharge
By performing medication reconciliation, the ward pharmacist would have
known if there is any balance medicines from the previous supply. If there is
balance of medication and is found to be in a good condition, it should be
reused as far as possible. Any excess or remaining previous medications that
are discontinued in the ward should be returned to the pharmacy. The aim of
this scheme is to optimize the use of current medications kept by patients
and reduce wastage.
3.7.4
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
29
Ward Pharmacy
Activities
3.7.3
4.0
Other
4.0
Activities
OTHER ACTIVITIES
4.2
4.3
4.4
4.5
4.6
4.1
Other Activities
30
Benzodiazepine
Carbamazepine
Digoxin
Lithium
Phenobarbital
Phenytoin
Theophylline
Valproic acid
Vancomycin
Paracetamol
Salicylates
Tacrolimus
Cyclosporine
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Other
4.2
Activities
4.0
Drug Availability
Drug Identification
Dosage/Administration
Indication
Interaction
Contraindication / Precaution
4.3
It is the pharmacist's responsibility to monitor and report any suspected adverse drug
reactions (ADR).
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
31
Other Activities
4.0
Other
Activities
Other Activities
A description of the adverse reactions and the suspected drug should be recorded in
the patient's bed head ticket / case note. The patient should be informed of the reaction
and adequate advice given taking care to avoid legal implications. An allergy card should
be given to the patient for documentation and as a form of alert for future drug use. The
number of Adverse Drug Reaction events should be recorded in the Clinical Pharmacy
Report Form (CP3). The data should be analysed to study trends in the occurrence of
ADRs to identify drugs which are commonly implicated, changes in the frequency of
occurrence and at risk groups. This information should be presented to the Drugs &
Therapeutics Committee if deemed necessary.
4.4
A medication error is defined as any preventable event that may cause or lead to
inappropriate medication use or patient harm while the medication is in the control of
the health care professional, patient, or consumer. Such events may be related to
professional practice, health care products, procedures and systems, including
prescribing, order communication, product labelling, packaging and nomenclature,
compounding, dispensing, distribution, administration, education, monitoring and use.
When reporting errors, please consider the following:
1. Describe the error or preventable adverse drug reaction. What went wrong?
2. Was this an actual medication error (reached the patient) or are you expressing
concern about a potential error or writing about an error that was discovered
before it reached the patient?
3. Patient outcome
4. Type of practice site (hospital, private office, retail pharmacy, drug company,
long-term care facility, etc)
5. The generic name (INN or official name) of all products involved
6. The brand name of all products involved
32
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Other
Activities
4.0
4.5
4.6
Each hospital / institution should have its own drug formulary adapted from the MOH
drug formulary based on local needs and functions. The hospital formulary may not
include all drugs in the MOH formulary. Newly-approved MOH drugs should follow the
local hospital policy for inclusion into the hospital formulary. Formulary drugs should
be the preferred choice of use at all times.
Drugs not listed in the MOH formulary are called Non-MOH Formulary Medications and
should not be prescribed before getting prior approval from the Director General of
Health. However, when non-hospital formulary drugs are strongly indicated (in
circumstances such as life-threatening situations or no other alternatives are available),
it should go through the proper procedure for approval before it can be obtained.
Ward Pharmacists in collaboration with the DIS pharmacist should ensure that nonMOH formulary drug requests for inpatients are rational and based on current evidence.
The prescriber should submit the request by using the 'KPK 01' Form with justification
by the respective Head of Department. All requests should be submitted to the
Pharmaceutical Services Division, MOH for approval by the Director General of Health.
The pharmacy department should monitor the non-MOH formulary drug usage once it
is available in the hospital.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
33
Other Activities
5.0
Documentation
5.0
DOCUMENTATION
Data collection through systematic documentation can be used for future planning
and expansion of pharmacy services in the country. Drug information enquiries during
the ward rounds should also be recorded in the Clinical Pharmacy Report Form. Areas
of national importance such as cost savings and medication error reduction can be
utilised to enhance a particular service. Please refer appendices for types of forms
used in Inpatient Pharmacy Practice.
5.1
Please refer to Chapter 2.1 for the use of the UDS forms.
5.2
Introduction
Documentations
As patients who are admitted to the ward may already be on some form of
medication, it is important to obtain this information prior to initiating treatment
except in an emergency setting.
A patient's treatment may be improved by an accurate drug history which
highlights drug related causes for previous treatment failure, previous and
potential adverse reactions, interactions, allergic, compliance, etc. The
medication history should be filed together with patients medical progress notes
(original copy) and for pharmacy record (carbonized copy) to facilitate easy
reference during the patient's stay in hospital.
Objectives
34
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Documentation
5.0
B.
C.
D.
Drug History
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
35
Documentations
A.
5.0
Documentation
E.
Pharmacists Notes
5.2.2
Introduction
Continuous pharmaceutical monitoring is essential to achieve optimum outcome
from the care plan which has been designed for the patient.
Objectives
Documentations
Form Contents
The form is divided into 5 main sections:
Section 1 - Appendix 10a
Section 2 - Appendix 10b & 10c
Section 3 - Appendix 10d &10e
Section 4 - Appendix 10f & 10g
: Patient's Profile
: Patient's Medication
: Lab Investigations
: Pharmaceutical Care Issues / Plan
/ Outcome
: Discharge Medication
36
Section 1
Obtain information from patient's BHT and Medication History
Assessment Form (Form CP1). If required interview patients for
further information.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Documentation
5.2.3
5.0
Section 2
Obtain information of medications which the patient has been
prescribed / is on from the Medication Chart. Record complete drug
regimen, date start and date stopped.
Section 3
Obtain information from BHT or Hospital Laboratory Data Retrieving
System. Record significant lab values related to the pharmaceutical
care plan and treatment goal.
Section 5
Record all discharged medication, and write the next appointment
date.
Introduction
Objectives
Forms Contents
This form is divided into 4 sections.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
37
Documentations
Data collection is critical towards justifying for the future expansion of clinical
pharmacy services and professional development and recognition in this country.
5.0
Documentation
38
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Documentation
5.0
D. Follow Up Required
5.2.4
Introduction
The Discharge Referral Note (Appendix 12) should serve as a pharmacy
discharge summary to be given to the primary care pharmacist or doctor. The
patient should also be given the Discharge Referral Note for provision of further
counselling and be informed that he / she is required to see the pharmacist in the
follow-up facility.
The ward pharmacist identifies patients who require further monitoring for
referral. The patient's diagnosis, medication list and discharge instructions in
the patient's case notes should be reviewed. Pharmacists should fill in the
Discharge Referral Note (CP4 - Appendix 10) to ensure further reviewing or
counselling by the pharmacist in other healthcare setting takes place. All PCIs
and action taken should be documented in the patient's case notes.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
39
Documentations
6.0
References
6.0
REFERENCES
Dooley, M. J., Allen, K. M., Doecke, C. J., et al. 2003. A Prospective
Multicentre Study of Pharmacist Initiated Changes to Drug Therapy and
Patient Management in Acute Care Government Funded Hospitals. Br.
Journal Clinical Pharmacology, 2003 : 67;4 : 513-21.
Kok Thong Wong, Siang Kwang Lim, Ruhaiyem Yahaya et al. 2001.
Guidelines Towards Excellence in Clinical Pharmacy Practice. Petaling
Jaya: Pharmaceutical Services Division, Ministry of Health.
Mohd Syafiq Abdullah, Kok Thong Wong, Rosnani Hashim et al. 1996.
Clinical Pharmacy Practice in the Malaysian Health Service: Concept
and Manual. Petaling Jaya: Pharmaceutical Services Division, Ministry
of Health.
Pharmaceutical Services Division, Ministry of Health. 2009. Requirement
for the Development of Pharmacy Facilities. Petaling Jaya:
Pharmaceutical Services Division, Ministry of Health.
References
40
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendices
7.0
7.0
APPENDICES
Appendix 1
Appendix 2
Advice Note
Appendix 3
Intervention Note
Appendix 4
Appendix 5
Referral Letter
Appendix 6
Appendix 7
Discharge Summary
Appendix 8
Appendix 9
Appendix 10
Appendix 11
Appendix 12
Appendix 13
Appendix 14
Appendix 15
Appendices
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
41
Appendices
Appendices
42
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 1
MEDICATION CHART
NAME : ...................................................
AGE
I/C : ........................................................
WEIGHT
: ..
R/N
DIAGNOSIS : ..
: ...................................................
MEDICATION RECORD
Date
Time
Name/Ward/Bed
DRUG
Date
Prescriber's
signature & stamp
Route
Freq
Date
Prescriber's
signature & stamp
Route
Freq
Prescriber's
signature & stamp
Route
DRUG
Freq
Duration
Date
Prescriber's
signature & stamp
Route
Freq
Dose
Duration
Date
Dose
Duration
Duration
Date
Appendices
Dose
ALLERGY
Prescriber's
signature & stamp
Route
Freq
Duration
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
43
Appendix 2
AGE
I/C : ........................................................
WEIGHT
: ..
R/N
DIAGNOSIS : ..
: ...................................................
MEDICATION RECORD
ALLERGY
Note
Appendices
44
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 3
Inpatient Pharmacy
Hospital ________________
ADVICE NOTE
Date :___________ Time :_________
Patient
: _________________________________________________________________________
I.C. No.
: _____________________________
R/N
: ______________________
Ward
: _____________
Bed No.
: _______________
Age
: ___________ years
Weight
: ________ kg
Diagnosis: _____________________________________________________
Dear Pharmacy staff,
With regards to this patient, we wish to advice the following:
New admission
Discharged / Deceased
Transferred from Ward _______
to Ward _______
Appendices
__________________________
Sign & Stamp
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
45
Appendix 4
Inpatient Pharmacy
Hospital ________________
INTERVENTION NOTE
__________________________________________________________________________________
Dear Doctor / Staff Nurse,
Kindly ammend this patient's prescription as per the following:
Specialist's signature required (for List A drugs)
LP form incomplete / required
Prescriber's signature missing
No CMR
Clarify drug name
Clarify patient's name / bed number
Other: ________________________________________
________________
Date
____________________________
Sign & Stamp
Appendices
46
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 5
Unit Dose Dispensing Checklist
Inpatient Pharmacy Service, Hospital ................................
WARD:
YEAR:
Month
JANUARY
SATELLITE:
FEBRUARY
MARCH
Received by:
Charted:
No. Errors:
Checked:
Dispensed:
Received by:
Charted:
No. Errors:
Checked:
Dispensed:
Received by:
Charted:
No. Errors:
Checked:
Dispensed:
Date
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Appendices
25
26
27
28
29
30
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
47
Appendix 6
KEMENTERIAN KESIHATAN MALAYSIA
SURAT RUJUKAN
HOSPITAL ______________________
Tarikh Temujanji:
:
:
Nama Pesakit
No.K/P
Jabatan / Unit
Masa
Umur
Jantina :
Results of Investigations :
Diagnosis
Treatment
Purpose of Referral
Tandatangan
Tel
Appendices
: Diberi kepada pesakit (untuk diberi kepada doktor di institusi yang dirujuk)
Salinan Kedua
Salinan Ketiga
48
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 7
BUKU DAFTAR PEMBEKALAN UBAT
(Drug Supply Registry Book)
No Rujukan
Borang
Sumber
Rujukan
(Hospital
asal yang
merujuk)
Kos (RM)
Tempoh
pesakit
dirujuk
Jumlah
Kos (RM)
Appendices
Tarikh
: _______________
Jumlah
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
49
Appendix 8
Inpatient Pharmacy
Hospital ________________
DISCHARGE SUMMARY
WARD: __________
Reg. No.
Patients Name
___________________
(Staff Nurses Name)
Date : _____________
Appendices
50
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendices
Appendix 9a
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
51
Appendix 9b
Appendices
52
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 10a
CP2
PHARMACOTHERAPY REVIEW
PHARMACOTHERAPY
REVIEW
Name :
Race : M / C / I / Others
MRN :
Ht/Wt :
Age :
Gender : M / F
DOA :
Ward/Bed :
Chief Complaint:
Social/Family History:
Review of system:
BP:
mmHg
PR:
p/min
RR:
T:
b/min
O
Smoking
Alcohol
Drug
Abuse
Pregnant
Compliance Evaluation:
Appendices
Diagnosis/Surgical Procedure:
Pind 1//10
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
53
Appendix 10b
WARD MEDICATION
DATE START
DATE STOP
Appendices
ELECTROLYTE THERAPY
CARDIOVASCULAR
ANTIBIOTIC
DRUG / REGIMEN
54
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 10c
WARD MEDICATION
DATE START
DATE STOP
OTHERS
DIABETES
DRUG / REGIMEN
Dopa
Dobu
Norad
Mida
Morp
Mida/Morp
Appendices
INFUSION CHART
DATE
I/O
CHART
Insulin
INPUT
OUTPUT
BALANCE
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
55
FBC
BUSE / Renal Profile
Urea
Na
K
Cl
Ca
Mg
PO4SCr
ClCr
1.7-8.3 mmol/L
135-145 mmol/L
3.5-5.0 mmol/L
96-106 mmol/L
2.1-2.6 mmol/L
0.7-1.3 mmol/L
0.8-1.45 mmol/L
64-122 umol/L
105-150 mL/min
Liver
profile
Albumin
T.Bilirubin
T.Protein
ALP
ALT
35 <20
66 53 <32
Coag.
profile
PT
APTT
INR
10-13.5 sec
26 - 42 sec
<1.5
Cardiac
enzymes
CK
LDH
AAT
24 - 195 u/l
0 - 248 u/l
<37
ABG
pH
pCO2
pO 2
HCO3
O2 sat
7.35-7.45
35-45mmHg
72-100mmHg
22-29mmol/L
90-95%
Others
RBS
< 11 mmol/L
BP
TEMP
RR
PR
12 - 18 b/min
60 - 100 p/min
Appendices
TWBC
Hb
RBC
HCT
Platlet
Vital signs
Appendix 10d
50 g/L
umol/L
87 g/L
141 u/L
u/L
Date
(sampling)
Sources/sample
M/organism
Sensitivity
Resistant
C&S
Date
56
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 10e
10
11
12
13
14
15
16
17
18
19
20
Appendices
Lipid
Date
T. Chol
C-TG
C-HDL
C-LDL
<5.7 mmol/L
<1.7 mmol/L
>1.7mmol/L
<3.9 mmol/L
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
57
Appendix 10f
DATE
PHARMACIST RECOMMENDATION
OUTCOME
Appendices
58
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 10g
PHARMACIST RECOMMENDATION
OUTCOME
Appendices
DATE
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
59
Appendix 10h
DISCHARGE MEDICATION
Appendices
NEXT TCA:
60
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 11a
CLINICAL PHARMACY REPORT FORM
CP3
Routine Rounds
Grand Rounds
Pharmacist Rounds
Number of Cases Clerked
Number of Cases Reviewed
Number of Patients in Ward
Number of Medication History (CP1) Taken
Description
Number of
Number of
interventions
interventions
Request / Information
Number Total
Provided
accepted
(1)
Incomplete
Prescription
Patient data
Drug
Drug Toxicity
Dose
Drug Dosage
Frequency
Therapeutic Efficacy
Duration
Drug Indication
Drug Interaction
Drug
Pharmacokinetic
(2)
Incorrect/
Dose
Inappropriate/
Inadequate Frequency
Duration
Regimen
Polypharmacy
(3)
Inappropriate Contraindication
Prescription Drug Interaction
TPN
General Product Information
Pharmaceutical Availability
Pharmaceutical Compatibility
Pharmaceutical Identification
Incompatibility
Unclear Handwriting
Authenticity of
(4)
Miscellaneous Prescription/
Prescriber
Error
Suggest For Vital
Signs Monitoring/
Laboratory
Investigation
TOTAL INFORMATION
PROVIDED
COUNSELLING
Bedside Counselling
TDM
Discharge Counselling
TPN
Group Counselling
TOTAL INTERVENTIONS
Appendices
Drug Administration
GRAND TOTAL
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
61
Appendix 11b
C: DESCRIPTION OF REQUESTS / INTERVENTIONS ENCOUNTERED
D: FOLLOW-UP REQUIRED
No
FOLLOW-UP
CHECKLIST
SIGN
Appendices
..
Pharmacist Sign & Stamp
Date:
Pin. 1/10
62
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendix 12
Appendices
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
63
Appendix 13
Appendices
64
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
Appendices
Appendix 14
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
65
Appendix 15
BORANG LAPORAN ADUAN PRODUK
YANG BERDAFTAR DENGAN PIHAK BERKUASA KAWALAN DADAH
Product Complaint Form for Products Registered with the Drug Control Authority
i. MAKLUMAT PRODUK
Particulars of Product
NAMA PRODUK:
Name of Product
NO. KELOMPOK:
Registration Number
Batch Number
TARIKH DIKILANGKAN:
TARIKH LUPUT:
Manufacturing Date
Expiry Date
ADUAN KUALITI:
Complaint on product quality
....................................................
ADUAN EFIKASI:
Complaint on product efficacy
Bagi masalah efikasi, kerjasama tuan/puan diminta supaya memberi maklumbalas objektif seperti:- % pesakit yang menghadapi masalah
- Adakah masalah berlaku selepas brand switching
- Objective findings seperti BP reading, RBS dll yang boleh menyokong aduan bahawa produk
kurang berkesan.
Kindly provide us with objective feedback such as:
- % patients having similar problems
- Was the problem occurring after brand switching
- Objective findings such as BP reading, RBS etc to support the complaint on the efficacy of the product
.........
.
...........................
iii. MAKLUMAT PELAPOR
Particulars of Complainant
NAMA:
JAWATAN/PEKERJAAN:
Name
Designation/Occupation
TELEFON:
FAX:
Telephone
Fax
TANDATANGAN:
Signature
66
TARIKH:
Date
SEKSYEN SURVEILANS & ADUAN PRODUK
PUSAT PASCA PENDAFTARAN PRODUK
BIRO PENGAWALAN FARMASEUTIKAL KEBANGSAAN
KEMENTERIAN KESIHATAN MALAYSIA
JALAN UNIVERSITI, PETI SURAT 319
46730 PETALING JAYA
Fax: 603-79567151
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
8.0
GLOSSARY
2.
Compliance aid - Any device such as pillbox, pamphlet or timetable guide that
helps to improve the patient's compliance to medication
3.
4.
5.
6.
7.
8.
9.
10.
11.
Routine round - Daily ward round between the ward pharmacists, medical officer
with or without the specialist or consultant.
12.
13.
14.
No. of cases clerked - Cases clerked for the first time during the current admission
15.
No. of cases reviewed - Clerked cases that are reviewed on the following days
16.
Chief complaints (CC) - Main complaints made by the patients during admission. It
should be documented as layman term
Glossary
1.
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia
67
17.
19.
20.
22.
Health Facility - Hospital, Health Clinic and Health Institution under Ministry of
Health
23.
Second Copy - a referral letter that is used to refer patient from one facility to
another
24.
25.
26.
Glossary
68
Guidelines for Inpatient Pharmacy Practice : Pharmaceutical Services Division Ministry of Health Malaysia